News | August 16, 2022
Marksans Pharma posts Q1FY23consolidated PAT at Rs. 59.71 Cr
The company has reported total income of Rs. 450.26 crores during the period ended June 30, 2022.
The company has reported total income of Rs. 450.26 crores during the period ended June 30, 2022.
Quetiapine Extended-Release Tablets are indicated for the treatment of Schizophrenia, Bipolar disorder and adjunctive treatment of Major Depressive Disorder (MDD)
The company has reported total income of Rs. 403.38 crores during the period ended June 30, 2022.
The company has reported total income of Rs. 65.19 crores during the period ended June 30, 2022.
Based on DESTINY-Lung02 results which showed AstraZeneca and Daiichi Sankyo’s Enhertu reported a confirmed objective response rate of 57.7% in patients with HER2-mutant disease
Company creates Younger T Cells for fighting cancer using its NR2F6 technology
MeitY will provide technical support for digitalisation of the Ayush Sector under the Ayush Grid project for a period of three years
Investment in response to increased demand for North American-based chemistry services
Apollo Hospital Group completed the acquisition of a hospital asset in Gurugram for a consideration of around Rs 450 crore.
The company has reported total income of Rs. 6276.54 crores during the period ended June 30, 2022.
Subscribe To Our Newsletter & Stay Updated
